Home > Healthcare > Medical Devices > Diagnostic Devices > Spirometer Market

Spirometer Market - By Product (Devices, Software, Consumables & Accessories), Technology (Peak Flow Meters, Volume & Flow Measurement), Application (Asthma, COPD, Cystic & Pulmonary Fibrosis), End-use (Hospital, Homecare) – Global Forecast, 2024 – 2032

  • Report ID: GMI8283
  • Published Date: Feb 2024
  • Report Format: PDF

Spirometer Market Size

Spirometer Market size was valued at USD 993.8 million in 2023 and is estimated to grow at 9.6% CAGR from 2024 to 2032, due to the escalating prevalence of respiratory diseases, such as asthma, COPD, and cystic fibrosis. This rise in respiratory conditions is driving the need for spirometry devices for diagnosis and management. The demand for spirometers is likely to expand as they play an increasingly crucial role in monitoring and treating respiratory ailments.
 

Spirometer Market

As respiratory health challenges are persisting and healthcare practices are evolving, the product demand will remain high to ensure continued support for diagnosing and managing respiratory diseases. For instance, in December 2023, the WHO European Region announced a rise in respiratory infections, including RSV, COVID-19, and influenza. This surge is underscoring the importance of spirometry devices in diagnosing and managing respiratory illnesses, especially among vulnerable populations, such as young children and at-risk groups.

The market is expected to further expand due to the increasing popularity of home healthcare and self-monitoring. This factor is driving the development of user-friendly and affordable spirometry devices for home use as they are more accessible, allowing individuals to monitor their respiratory health from the comfort of their own homes. Lastly, advancements in technology are making spirometers even more user-friendly and cost-effective to extend their reach and empower individuals to take proactive measures for their respiratory well-being.
 

For instance, in January 2024, the FDA granted 510(k) clearance to NuvoAir for its Air Next spirometer's in-home use. This device enables individuals to perform lung function tests at home by facilitating continuous monitoring for conditions, such as COPD, asthma, and ALS while enhancing accessibility and convenience for patients managing respiratory health.
 

In addition, the demand for spirometry testing is increasing due to the growing emphasis on preventive healthcare measures. Routine health check-ups are incorporated with spirometry, particularly for individuals with a family history of respiratory diseases or exposure to environmental pollutants. The strong focus on the early detection and management of respiratory conditions along with the rise in proactive healthcare strategies for individuals at risk will favor the market growth.
 

However, the high initial costs for advanced models will hinder the widespread product adoption to some extent. The lack of skilled professionals for accurate interpretation is also posing barriers to effective utilization. On the other side, the ongoing efforts in training and cost reduction initiatives will gradually mitigate these challenges to facilitate broader accessibility and usage.
 

Spirometer Market Trends

The rise in government initiatives for focusing on controlling and managing respiratory diseases along with reimbursement policies for diagnostic tests are other important trends driving the industry growth. This ongoing commitment is ensuring accessibility to spirometry testing for facilitating early detection and management of respiratory conditions, thereby improving public health outcomes, and sustaining the market growth trajectory.
 

For instance, in November 2023, China initiated a comprehensive approach to advancing COPD care. This involved nationwide interventions, including screening and a national program for enhancing lung function test utilization. Through these efforts, spearheaded by the Chinese Government, the capacity for COPD screening and management in primary healthcare has significantly improved, potentially boosting the demand for spirometers. Furthermore, continuous advancements in spirometry devices are expanding their usability. Portable and handheld models are being developed for enabling wireless connectivity and integration with EHR systems. These enhancements will continue to drive market growth and make spirometry more accessible and convenient in the future.
 

Spirometer Market Analysis

Spirometer Market, By Product, 2021 – 2032 (USD Million)

Based on product, the devices segment recorded significant revenue share in 2023 and is anticipated to reach over USD 1.4 billion by 2032. This is due to the ongoing technological advancements, including the development of portable and integrated devices. Of late, there have been significant innovations in spirometer devices to enhance usability and connectivity. Additionally, the integration of spirometry devices with electronic health records along with the continuous improvements and increasing adoption rates will fuel the product demand.

 

Spirometer Market, By Technology (2023)

Based on technology, the spirometer market is segmented into volume measurement, flow measurement, and peak flow meters. The volume measurement segment is anticipated to reach USD 962.9 billion by 2032, owing to the strong need to accurately diagnose and monitor respiratory ailments, including asthma, COPD, and restrictive lung diseases. Spirometers deployed with volume measured technology are preferred by professional organizations and guidelines, emerging necessary in hospitals, clinics, and diagnostic laboratories for routine respiratory disease testing and evaluation. The rapid advances in spirometry technology leading to the development of more sophisticated and user-friendly volume-based spirometers will drive the market expansion.
 

Based on application, the spirometer market from the COPD segment may reach USD 964 million by 2032. This is majorly propelled by the rising prevalence of COPD (chronic obstructive pulmonary disease) globally. Continuous advancements in spirometry technology are enabling more accurate diagnosis and monitoring of COPD progression. Healthcare providers increasingly rely on spirometry testing for early detection and personalized treatment strategies. Moreover, the ongoing R&D efforts aimed at enhancing the capabilities in managing COPD and ensuring its continued prominence will favor the segment growth in the coming years.
 

North America Spirometer Market, 2020 – 2032 (USD Million)

North America spirometer market size accounted for USD 368.9 million in revenue in 2023 and is predicted to witness 8.9% CAGR through 2032. The growth can be ascribed to the expanding utilization of telehealth services, particularly due to the onset of the COVID-19 pandemic. Spirometry devices are increasingly employed in the region for remote consultations and monitoring. This trend will be fueled by advancements in telehealth technology and the growing acceptance of virtual healthcare solutions. The ongoing telehealth revolution will thus play a key role in the regional industry growth.
 

Spirometer Market Share

Prominent players in the spirometer industry are continuously innovating and focusing on collaborative ventures to gain competitive edges. Expansion strategies including product advancements, mergers, acquisitions, and partnerships are helping them enhance their market presence while widening their customer base.
 

Spirometer Market Companies

Major firms operating in the spirometer industry include:

  • COSMED srl
  • FUKUDA SANGYO CO., LTD.
  • Geratherm Medical AG
  • Hill-Rom Holdings, Inc. (Baxter International)
  • Koninklijke Philips N.V.
  • ndd Medical Technologies
  • Schiller AG
  • Sibelmed
  • Teleflex Incorporated
  • Vitalograph
  • Vyaire Medical Inc.
     

Spirometer Industry News

  • In March 2023, Clario collaborated with ArtiQ to integrate AI into spirometry data collection for clinical trials. This partnership enabled scalable AI over-reading while ensuring accurate data collection and patient benefits in respiratory trials.
  • In August 2022, AstraZeneca India partnered with Alveofit for providing IoT-enabled handheld spirometers to clinics and last-mile hospitals.
     

Spirometer market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report


Market, By Product Type

  • Devices
    • Hand held
    • Table top
    • Desktop
  • Software
  • Consumables & Accessories

Market, By Technology

  • Volume measurement
  • Flow measurement
  • Peak flow meters

Market, By Application

  • Asthma
  • COPD
  • Cystic fibrosis
  • Pulmonary fibrosis
  • Other applications

Market, By End-use

  • Hospitals and clinics
  • Homecare settings
  • Clinical laboratories
  • Other end-users

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • UAE
    • Rest of Middle East and Africa

 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The spirometer industry size was USD 993.8 million in 2023 and is estimated to grow at 9.6% CAGR from 2024 to 2032, due to the escalating prevalence of respiratory diseases, such as asthma, COPD, and cystic fibrosis.

The devices segment in the market is anticipated to reach over USD 1.4 billion by 2032, led by ongoing technological advancements, including the development of portable and integrated devices parameters.

North America market size accounted for USD 368.9 million in revenue in 2023 and is predicted to witness 8.9% CAGR through 2032 fueled by advancements in telehealth technology and the growing acceptance of virtual healthcare solutions.

COSMED srl, FUKUDA SANGYO CO., LTD., Geratherm Medical AG, Hill-Rom Holdings, Inc. (Baxter International), Koninklijke Philips N.V., ndd Medical Technologies, Schiller AG, Sibelmed, Teleflex Incorporated, Vitalograph, and Vyaire Medical Inc.

Spirometer Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 11
  • Tables & Figures: 266
  • Countries covered: 22
  • Pages: 130
 Download Free Sample